Ketamine Pilot Study

Pilot Study: Ketamine for Acute Pain After Rattlesnake Envenomation

NCT05379179•Meghan Spyres

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Rattlesnake Envenomation

Interventions

Ketamine

Fentanyl

Locations

United States

Locations (1)

Banner - University Medical Center, Phoenix campus

Phoenix, Arizona, United States

Key Dates

Start Date

June 20, 2022

Primary Completion Date

August 27, 2022

Completion Date

August 27, 2022

Last Updated

February 14, 2024

Sponsors

Lead Sponsor

Meghan Spyres

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 14, 2024Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions